GlassScriptPhysician profile
Madison P Austin
NPI 1962097675
$7,365.49
in general payments reported to CMS, 2019-2025
35 companies · $1,891 in 2025
The $1,891 reported for 2025 was more than what 90% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $888 · 2022: $1,174 · 2023: $1,765 · 2024: $1,647 · 2025: $1,891.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,261 · Gift: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,261.22 |
| Gift | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,338.30 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Dexcom, INC. | $730.39 | 2021-2025 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $596.75 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Insulet Corporation | $489.03 | 2021-2025 | Omnipod |
| Sanofi-Aventis U.S. LLC | $465.33 | 2021-2025 | |
| Novo Nordisk INC | $455.79 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $387.16 | 2021-2025 | Jardiance, Tradjenta |
| Corcept Therapeutics | $386.40 | 2022-2025 | Korlym |
| Tandem Diabetes Care, INC. | $354.19 | 2021-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Merck Sharp & Dohme LLC | $229.05 | 2021-2023 | Belsomra, Steglatro, Steglujan |
| Astrazeneca Pharmaceuticals LP | $227.81 | 2021-2023 | Farxiga |
| Mannkind Corporation | $197.13 | 2021-2025 | |
| Abbvie INC. | $190.77 | 2021-2025 | |
| Sequel Med Tech, LLC | $160.81 | 2025 | Twiist |
| Ascensia Diabetes Care US INC. | $148.31 | 2023-2024 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $129.99 | 2022-2024 | Senza |
| Exact Sciences Corporation | $126.50 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $107.98 | 2023-2025 | |
| Beta Bionics, INC. | $106.98 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Abbott Laboratories | $69.28 | 2023-2025 | Freestyle Libre 3 |
| Antares Pharma, INC. | $68.14 | 2023-2025 | Xyosted, Nocdurna, Tlando |
| Amgen INC. | $67.81 | 2024-2025 | Tepezza, Evenity, Prolia |
| Medtronic, INC. | $52.34 | 2022-2025 | Minimed 780g |
| Glaxosmithkline, LLC. | $45.68 | 2023-2024 | Shingrix, Trelegy Ellipta, Arexvy |
| Cequr Corporation | $39.73 | 2024-2025 | Cequr Simplicity |
| Sandoz INC. | $26.59 | 2025 | Jubbonti |
| Radius Health, INC. | $22.26 | 2025 | Tymlos |
| Recordati_rare_diseases_inc. | $21.92 | 2025 | Isturisa |
| Ibsa Pharma INC. | $21.07 | 2025 | Tirosint, Licart, Flector |
| Amneal Pharmaceuticals LLC | $20.18 | 2025 | Unithroid |
| Janssen Pharmaceuticals, INC | $19.21 | 2025 | Spravato |
| Halozyme INC | $17.99 | 2023 | |
| Averitas Pharma INC. | $15.61 | 2023 | Qutenza |
| Eisai INC. | $15.09 | 2021 | |
| Zealand Pharma US, INC. | $13.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madison Austin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.